Ecallantide TFA
Ecallantide TFA (DX-88) is a recombinant plasma kallikrein inhibitor that blocks bradykinin generation. It is applied in research on hereditary angioedema (HAE), utilized in both in vitro assays and in vivo models to study acute attack pathways and therapeutic mechanisms.
Product Specifications
Field of Research
Immunology & Inflammation, Protein Biochemistry
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog